These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31144498)

  • 1. Functional Titanium Carbide MXenes-Loaded Entropy-Driven RNA Explorer for Long Noncoding RNA PCA3 Imaging in Live Cells.
    Wang S; Song W; Wei S; Zeng S; Yang S; Lei C; Huang Y; Nie Z; Yao S
    Anal Chem; 2019 Jul; 91(13):8622-8629. PubMed ID: 31144498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric DNA-Functionalized Titanium Carbide MXenes for Simultaneous Mapping of Dual Cancer Biomarkers in Living Cells.
    Wang S; Wei S; Wang S; Zhu X; Lei C; Huang Y; Nie Z; Yao S
    Anal Chem; 2019 Jan; 91(2):1651-1658. PubMed ID: 30567426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to Functional Titanium Carbide MXenes-Loaded Entropy-Driven RNA Explorer for Long Noncoding RNA PCA3 Imaging in Live Cells.
    Wang S; Song W; Wei S; Zeng S; Yang S; Lei C; Huang Y; Nie Z; Yao S
    Anal Chem; 2019 Nov; 91(21):14157. PubMed ID: 31589415
    [No Abstract]   [Full Text] [Related]  

  • 4. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
    Salameh A; Lee AK; Cardó-Vila M; Nunes DN; Efstathiou E; Staquicini FI; Dobroff AS; Marchiò S; Navone NM; Hosoya H; Lauer RC; Wen S; Salmeron CC; Hoang A; Newsham I; Lima LA; Carraro DM; Oliviero S; Kolonin MG; Sidman RL; Do KA; Troncoso P; Logothetis CJ; Brentani RR; Calin GA; Cavenee WK; Dias-Neto E; Pasqualini R; Arap W
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8403-8. PubMed ID: 26080435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors.
    Soares JC; Soares AC; Rodrigues VC; Melendez ME; Santos AC; Faria EF; Reis RM; Carvalho AL; Oliveira ON
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46645-46650. PubMed ID: 31765118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.
    Lemos AE; Ferreira LB; Batoreu NM; de Freitas PP; Bonamino MH; Gimba ER
    Tumour Biol; 2016 Aug; 37(8):11339-48. PubMed ID: 26960690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Rashnoo F
    Pathol Res Pract; 2022 Mar; 231():153800. PubMed ID: 35180654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
    Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
    Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Going viral? Linking the etiology of human prostate cancer to the
    Teixeira AA; Marchiò S; Dias-Neto E; Nunes DN; da Silva IT; Chackerian B; Barry M; Lauer RC; Giordano RJ; Sidman RL; Wheeler CM; Cavenee WK; Pasqualini R; Arap W
    EMBO Mol Med; 2017 Oct; 9(10):1327-1330. PubMed ID: 28751581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual electrochemical genosensor for early diagnosis of prostate cancer through lncRNAs detection.
    Sánchez-Salcedo R; Miranda-Castro R; de-Los-Santos-Álvarez N; Lobo-Castañón MJ
    Biosens Bioelectron; 2021 Nov; 192():113520. PubMed ID: 34311209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
    Lauer RC; Barry M; Smith TL; Thomas AM; Wu J; Du R; Lee JH; Rao A; Dobroff AS; Arap MA; Nunes DN; Silva IT; Dias-Neto E; Chen I; McCance DJ; Cavenee WK; Pasqualini R; Arap W
    Elife; 2023 Jan; 12():. PubMed ID: 36645410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detection.
    Marangoni K; Neves AF; Rocha RM; Faria PR; Alves PT; Souza AG; Fujimura PT; Santos FA; Araújo TG; Ward LS; Goulart LR
    Sci Rep; 2015 Jul; 5():12090. PubMed ID: 26174796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Peptides Self-Assembling on Titanium Carbide MXenes as Biosensing Interfaces for Activity Assay of Post-translational Modification Enzymes.
    Wang S; Zeng P; Zhu X; Lei C; Huang Y; Nie Z
    Anal Chem; 2020 Jul; 92(13):8819-8826. PubMed ID: 32468809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes.
    Ito S; Ueda T; Yokoyama A; Fujihara A; Hongo F; Ukimura O
    Cancer Gene Ther; 2022 Mar; 29(3-4):358-368. PubMed ID: 33758375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
    Deng J; Tang J; Wang G; Zhu YS
    Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspectives of improvement of the diagnosis of prostate cancer based on analysis of PCA3 gene expression].
    Toropovsky AN; Nikitin AG; Pavlova ON; Viktorov DA
    Urologiia; 2019 Jun; (2):82-86. PubMed ID: 31162907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.
    Salagierski M; Verhaegh GW; Jannink SA; Smit FP; Hessels D; Schalken JA
    Prostate; 2010 Jan; 70(1):70-8. PubMed ID: 19760627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling.
    Guo S; Zhang Y; Wang S; Yang T; Ma B; Li X; Zhang Y; Jiang X
    Toxicol Lett; 2021 Sep; 348():50-58. PubMed ID: 34052307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.